Novavax’s Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
(Adnkronos) – GAITHERSBURG, Md., Oct. 31, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the Nuvaxovid™ XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant,
